- Achieving the goal of rheumatoid arthritis treatment is more common in patients with moderate activity than high disease activity in the real clinical practice of the ATTRA National Registry of Biological Treatment2022 | First Faculty of Medicine, Central Library of Charles University
- Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation2016 | First Faculty of Medicine, Second Faculty of Medicine
- A case of lupus-like syndrome in a patient receiving adalimumab and a brief review of the literature on drug-induced lupus erythematosus2017 | Faculty of Medicine in Pilsen
- Issue of tuberculosis associated with TNF blocking treatment in the Czech Republic2006 | First Faculty of Medicine
- Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Science
- Fecal microbiome changes and specific anti-bacterial response in patients with ibd during anti-tnf therapy2021 | First Faculty of Medicine, Second Faculty of Medicine
- Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF TherapyPublication without faculty affiliation
- Low predictive value of histopathological scoring system for complications development in children with Crohn's disease2017 | Second Faculty of Medicine
- Serum and Mucosal CD30 in Pediatric Inflammatory Bowel Diseases: Useful Biomarker for Diagnosis and Disease Activity Monitoring?2023 | Second Faculty of Medicine, Third Faculty of Medicine
- Limited clinical significance of tissue calprotectin levels in bowel mucosa for the prediction of complicated course of the disease in children with ulcerative colitis2019 | Second Faculty of Medicine
- Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies2022 | First Faculty of Medicine
- Safety of vedolizumab and ustekinumab in the treatment of pregnant women with inflammatory bowel disease - a multicentre retrospective-prospective observational study2022 | First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Hradec Králové